The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Adenoviruses in the immunocompromised host
Open accessAbstract
Adenoviruses are among the many pathogens and opportunistic agents that cause serious infection in the congenitally immunocompromised, in patients undergoing immunosuppressive treatment for organ and tissue transplants and for cancers, and in human immunodeficiency virus-infected patients. Adenovirus infections in these patients tend to become disseminated and severe, and the serotypes involved are clustered according to the age of the patient and the nature of the immunosuppression. Over 300 adenovirus infections in immunocompromised patients, with an overall case fatality rate of 48%, are reviewed in this paper. Children with severe combined immunodeficiency syndrome and other primary immunodeficiencies are exposed to the serotypes of subgroups B and C that commonly infect young children, and thus their infections are due to types 1 to 7 and 31 of subgenus A. Children with bone marrow and liver transplants often have lung and liver adenovirus infections that are due to an expanded set of subgenus A, B, C, and E serotypes. Adults with kidney transplants have viruses of subgenus B, mostly types 11, 34, and 35, which cause cystitis. This review indicates that 11% of transplant recipients become infected with adenoviruses, with case fatality rates from 60% for bone marrow transplant patients to 18% for renal transplant patients. Patients with AIDS become infected with a diversity of serotypes of all subgenera because their adult age and life-style expose them to many adenoviruses, possibly resulting in antigenically intermediate strains that are not found elsewhere. Interestingly, isolates from the urine of AIDS patients are generally of subgenus B and comprise types 11, 21, 34, 35, and intermediate strains of these types, whereas isolates from stool are of subgenus D and comprise many rare, new, and intermediate strains that are untypeable for practical purposes. It has been estimated that adenoviruses cause active infection in 12% of AIDS patients and that 45% of these infections terminate in death within 2 months. In all immunocompromised patients, generalized illness involving the central nervous system, respiratory system, hepatitis, and gastroenteritis usually have a fulminant course and result in death. Treatments for adenovirus infections are of little proven value, although certain purine and pyrimidine analogs have shown beneficial effects in vitro and may be promising drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections
Lennette, E. H., Lennette, D. A., & Lennette, E. T. (1989) · Virtual Defense Library (Ministerio de Defensa) · Cited by 2,353
HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation
Laspia, M. F., Rice, A. P., & Mathews, M. B. (1989) · Cell · doi:10.1016/0092-8674(89)90290-0 · Cited by 571
Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines
Clercq, E. D., Sakuma, T., Baba, M., Pauwels, R., Balzarini, J., Rosenberg, I., & Holý, A. (1987) · Antiviral Research · doi:10.1016/s0166-3542(87)80004-9 · Cited by 515
Kitajewski, J., Schneider, R. J., Safer, B., Munemitsu, S. M., Samuel, C. E., Thimmappaya, B., & Shenk, T. (1986) · Cell · doi:10.1016/0092-8674(86)90383-1 · Cited by 363
WORLDWIDE EPIDEMIOLOGY OF HUMAN ADENOVIRUS INFECTIONS
SCHMTTZ, H., WIGAND, R., & HEINRICH, W. (1983) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113563 · Cited by 340
Infectious Gastroenteritis in Bone-Marrow-Transplant Recipients
Yolken, R. H., Bishop, C. A., Townsend, T. R., Bolyard, E. A., Bartlett, J., Santos, G. W., & Saral, R. (1982) · New England Journal of Medicine · doi:10.1056/nejm198204293061701 · Cited by 310
Molecular Epidemiology of Human Adenoviruses
Wadell, G. (1984) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-46494-2_7 · Cited by 276
Laboratory Diagnosis of Infectious Diseases Principles and Practice
Lennette, E. H., Halonen, P., Murphy, F. A., Balows, A., & Hausler, W. J. (1988) · Springer eBooks · doi:10.1007/978-1-4612-3900-0 · Cited by 263
Alternative Mechanisms for Activation of Human Immunodeficiency Virus Enhancer in T Cells
Nabel, G. J., Rice, S. A., Knipe, D. M., & Baltimore, D. (1988) · Science · doi:10.1126/science.2830675 · Cited by 257
A Large Outbreak of Epidemic Keratoconjunctivitis: Problems in Controlling Nosocomial Spread
Warren, D., Nelson, K. E., Farrar, J. A., Hurwitz, E. S., Hierholzer, J. C., Ford, E. S., & Anderson, L. J. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/160.6.938 · Cited by 128
Self-citationFatal disseminated adenovirus infection in a renal transplant recipient
Myerowitz, R. L., Stalder, H., Oxman, M. N., Levin, M. J., Moore, M., Leith, J. D., Gantz, N. M., Pellegrini, J., & Hierholzer, J. C. (1975) · The American Journal of Medicine · doi:10.1016/0002-9343(75)90267-3 · Cited by 121
Self-citationCunningham, A. L., Grohman, G. S., Harkness, J., Law, C. L. H., Marriott, D. J. E., Tindall, B., & Cooper, D. A. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.2.386 · Cited by 110
McClain, K. L., Gehrz, R. C., Grierson, H. L., Purtilo, D. T., & Filipovich, A. H. (1988) · PubMed · Cited by 109
Krilov, L. R., Rubin, L. G., Frogel, M., Gloster, E. S., Ni, K., Kaplan, M., & Lipson, S. M. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.2.303 · Cited by 108
Stalder, H., Hierholzer, J. C., & Oxman, M. N. (1977) · Journal of Clinical Microbiology · doi:10.1128/jcm.6.3.257-265.1977 · Cited by 98
Self-citationAdenovirus colitis in the acquired immunodeficiency syndrome
Janoff, E. N., Orenstein, J. M., Manischewitz, J. F., & Smith, P. D. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90272-m · Cited by 95
Fatal adenovirus meningoencephalitis in a bone marrow transplant patient
Davis, D. G., Henslee‐Downey, P. J., & Markesbery, W. R. (1988) · Annals of Neurology · doi:10.1002/ana.410230412 · Cited by 89
Takafuji, E. T., Gaydos, J. C., Allen, R. G., & Top, F. H. (1979) · The Journal of Infectious Diseases · doi:10.1093/infdis/140.1.48 · Cited by 85
SUBACUTE FOCAL ADENOVIRUS ENCEPHALITIS
Chou, S. M., Roos, R. P., BURRELL, R., Gutmann, L., & HARLEY, J. B. (1973) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-197301000-00003 · Cited by 64
Buehler, J. W., Finton, R. J., Goodman, R. A., Choi, K., Hierholzer, J. C., Sikes, R. K., & Elsea, W. R. (1984) · Infection Control · doi:10.1017/s0195941700062238 · Cited by 50
Self-citationVenkatesh, L., Arens, M. Q., Subramanian, T., & Chinnadurai, G. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8746 · Cited by 50
Adenovirus-related hemophagocytic syndrome after bone marrow transplantation.
Levy, J., Ra, W., Cs, A., & Bayever, E. (1990) · PubMed · Cited by 48
CHARACTERIZATION OF ADENOVIRUS ISOLATES FROM AIDS PATIENTSa
Horwitz, M. S., Valderrama, G., Hatcher, V. A., Kern, R., deJong, P. J., & Spigland, I. (1984) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1984.tb37132.x · Cited by 35
Isolation of an Adenovirus 32 Strain from Human Brain in a Case of Subacute Encephalitis
Roos, R. P., Chou, S. M., Rogers, N. G., BASNIGHT, M., & Gajdusek, D. C. (1972) · Experimental Biology and Medicine · doi:10.3181/00379727-139-36204 · Cited by 35
Immunological and biochemical characterization of human adenoviruses from subgenus B
Wigand, R., Sehn, N., Hierholzer, J. C., de Jong, J. C., & Adrian, T. (1985) · Archives of Virology · doi:10.1007/bf01310554 · Cited by 27
Self-citationVentura, A. M., Arens, M. Q., Srinivasan, A., et al. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1310 · Cited by 24
Adenovirus Type 2 Encephalitis and Concurrent Epstein-Barr Virus Infection in an Adult Man
West, T. E., Papasian, C. J., Park, B. H., & Parker, S. W. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04210090083023 · Cited by 22
Lethal Disseminated Adenovirus Type 1 Infection in a Patient with Chronic Lymphocytic Leukemia
Ljungman, P. T., Ehrnst, A., Björkstrand, B., Hellström, E., Ingelman-Sundberg, H., Juliusson, G., & Lönnqvist, B. (1990) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549009027103 · Cited by 18
Coldiron, B. M. (1988) · Archives of Dermatology · doi:10.1001/archderm.1988.01670050012006 · Cited by 13
Cited by
Rapid and quantitative detection of human adenovirus DNA by real‐time PCR
Heim, A., Ebnet, C., Harste, G., & Pring‐Åkerblom, P. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10382 · Cited by 820
CD46 is a cellular receptor for group B adenoviruses
Gaggar, A., Shayakhmetov, D. M., & Lieber, A. (2003) · Nature Medicine · doi:10.1038/nm952 · Cited by 792
Boivin, G., Abed, Y., Pelletier, G., Ruel, L., Moisan, D., Côté, S., Peret, T. C. T., Erdman, D. D., & Anderson, L. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/344319 · Cited by 606
Adenoviruses in Immunocompromised Hosts
Echavarría, M. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00052-07 · Cited by 512
Metadata
- Authors
- Hierholzer, J. C.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 1992-07
- Volume
- 5
- Issue
- 3
- Pages
- 262-274
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W1950423469
- Cited by
- 587
- References
- 29
- FWCI
- 10.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.